Noreen Browne
About Noreen Browne
Noreen Browne is the Associate Director Finance at Cruiserath Biologics, part of Bristol-Myers Squibb, with extensive experience in financial management within the pharmaceutical industry.
Current Role at Bristol-Myers Squibb
Noreen Browne serves as the Associate Director Finance at Cruiserath Biologics, a division of Bristol-Myers Squibb. In this role, she oversees financial operations and strategies. She is also functioning as the Financial Controller for Cruiserath Biologics, managing financial reporting and compliance. Her expertise in financial management supports the strategic goals of the biopharmaceutical manufacturer.
Previous Roles at Bristol-Myers Squibb
Prior to her current role, Noreen Browne worked as a Financial Accountant at Bristol-Myers Squibb in Swords from 2009 to 2016. Over her seven-year tenure in this position, she built a foundation in financial accounting and control. She joined Bristol-Myers Squibb in 2009 and has been with the company for over a decade, demonstrating consistent growth and leadership.
Experience at PricewaterhouseCoopers
Before joining Bristol-Myers Squibb, Noreen Browne worked at PricewaterhouseCoopers as an Auditor from 2004 to 2008, based in County Dublin, Ireland. During her four years at PwC, she gained significant experience in financial auditing, which provided her with a solid foundation in financial practices and standards.
Financial Management Expertise
With extensive experience in financial management within the pharmaceutical industry, Noreen Browne has developed a strong background in financial accounting and control. Her roles at Bristol-Myers Squibb have spanned from Financial Accountant to Financial Controller, with her leadership role at Cruiserath Biologics commencing in December 2017. Her expertise is instrumental in guiding the financial strategies and operations of the company.